Standout Papers

A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Tra... 2010 2026 2015 2020 673
  1. A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study) (2010)
    Flavio Vincenti, B Charpentier et al. American Journal of Transplantation

Immediate Impact

2 by Nobel laureates 1 from Science/Nature 59 standout
Sub-graph 1 of 24

Citing Papers

Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review
2025 Standout
The B7:CD28 family and friends: Unraveling coinhibitory interactions
2024 Standout
2 intermediate papers

Works of Mamta Agarwal being referenced

Belatacept-Based Immunosuppression in De Novo Liver Transplant Recipients: 1-Year Experience From a Phase II Randomized Study
2014
Five-Year Safety and Efficacy of Belatacept in Renal Transplantation
2010
and 2 more

Author Peers

Author Last Decade Papers Cites
Mamta Agarwal 934 330 463 369 18 1.4k
G. Russo 964 336 437 356 18 1.3k
Steven Steinberg 797 274 389 277 23 1.1k
Kim Rice 697 261 353 268 11 1.0k
Marie‐Christine Moal 667 324 383 210 25 1.0k
Argiris Asderakis 553 218 457 385 34 1.3k
N. L. Tilney 488 489 499 414 37 1.4k
John A. Daller 798 352 688 191 45 1.5k
Alexander C. Wiseman 664 177 490 157 35 1.1k
Scott Ames 510 250 494 383 33 1.3k
Dechu Puliyanda 591 251 321 288 43 1.1k

All Works

Loading papers...

Rankless by CCL
2026